IFNG and renal cell carcinoma: Generate a significant anti-tumor efficacy in both subcutaneous and orthotopic RCC tumor models by influx of tumor-infiltrating effector T cells. It has also attracted a broader spectrum of polyfunctional T cells into the TME and trigger resilient IFN-γ response